Savara CFO resigns for health reasons; COO promoted, shares authorized doubled to 600M

Filed June 8, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

• high

  CFO David Lowrance resigns effective July 15, 2026 due to health reasons. He'll receive severance and 12 months accelerated equity vesting. COO Robert Lutz promoted to combined CFO/COO role with $510K salary.

  Item 5.02 verify on EDGAR →
• high

  Stockholders approved doubling authorized common stock from 300M to 600M shares. Amendment filed and effective June 4, 2026. Provides capacity for future capital raises or acquisitions but enables potential dilution.

  Item 5.03 verify on EDGAR →
• medium

  Equity incentive plan expanded by 18.9M shares following stockholder approval. Increases employee compensation pool and will dilute existing shareholders as awards vest over time.

  Item 5.02 verify on EDGAR →